CDNA Caredx Inc

Price (delayed)

$53.55

Market cap

$2.77B

P/E Ratio

24.91

Dividend/share

N/A

EPS

$2.15

Enterprise value

$2.41B

?
Relative Growth: Rel. Growth: 90
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 56
Relative Profitability: Rel. Profitability: 97

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and ...

Highlights
Caredx's EPS has soared by 92% YoY
Caredx's net income has soared by 91% YoY

Key stats

What are the main financial stats of CDNA

CDNA stock price

How has the Caredx stock price performed over time
Intraday
1.73%
1 week
7.04%
1 month
18.16%
1 year
277.64%
YTD
184.24%
QTD
87.89%

Financial performance

How have Caredx's revenue and profit performed over time
Revenue
$458.09M
Gross profit
$323.33M
Operating income
$108.14M
Net income
$111.01M
Gross margin
70.6%
Net margin
24.2%
The operating income has surged by 134% year-on-year
Caredx's net income has soared by 91% YoY
Caredx's operating margin has soared by 75% YoY
The net margin has grown by 42% year-on-year

Price vs fundamentals

How does CDNA's price correlate with its fundamentals

Growth

What is Caredx's growth rate over time

Valuation

What is Caredx stock price valuation
P/E
24.91
P/B
6.5
P/S
6.02
EV/EBIT
22.41
EV/EBITDA
18.93
EV/Sales
5.26
Caredx's EPS has soared by 92% YoY
The stock's price to book (P/B) is 117% more than its 5-year quarterly average of 3.0 and 117% more than its last 4 quarters average of 3.0
The equity has increased by 36% from the previous quarter and by 30% YoY
The price to sales (P/S) is 141% more than the last 4 quarters average of 2.5 and 72% more than the 5-year quarterly average of 3.5
The revenue has increased by 34% YoY and by 11% QoQ

Efficiency

How efficient is Caredx business performance
CDNA's return on assets has surged by 103% year-on-year
The ROE has soared by 92% YoY
Caredx's ROS has soared by 69% YoY

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did Caredx financials performed over time
The company's quick ratio has surged by 60% YoY and by 49% QoQ
CDNA's current ratio is up by 39% year-on-year and by 35% since the previous quarter
The debt is 97% smaller than the equity
Caredx's debt to equity has shrunk by 57% YoY and by 50% QoQ
The debt has declined by 42% year-on-year and by 26% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.